Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (2134)
  2. Journal Article (1755)
  3. Review (262)
  4. Editorial (133)
  5. Research Letter (85)
  6. Correspondence (45)
  7. Book Section (31)
  8. Guidelines (25)
  9. Miscellaneous (13)
  10. Conference Paper (8)
Groups
  1. Department of Medicine (4172)
  2. Weinberg Fellows (2756)
  3. Hematologic Malignancies, Division of (2492)
  4. Solid Tumor Oncology Division (2422)
  5. Center for Hematologic Malignancies (1945)
  6. GSK Faculty (1879)

More Groups

People
  1. Sergio Giralt (433)
  2. Michael Scordo (389)
  3. Gunjan Shah (348)
  4. Miguel-Angel Perales (338)
  5. Sean Devlin (289)
  6. Marcel Van Den Brink (263)

More People

Years
  1. 2025 (343)
  2. 2024 (636)
  3. 2023 (600)
  4. 2022 (628)
  5. 2021 (503)
  6. 2020 (496)

More Years

Publications
  1. Blood (713)
  2. Journal of Clinical Oncology (685)
  3. Annals of Oncology (133)
  4. Clinical Cancer Research (131)
  5. Cancer Research (126)
  6. Biology of Blood and Marrow Transplantation (124)

More Publications

Publishers
  1. American Society of Hematology (806)
  2. American Society of Clinical Oncology (774)
  3. Elsevier Inc. (544)
  4. Nature Publishing Group (358)
  5. American Association for Cancer Research (352)
  6. Oxford University Press (211)

More Publishers

Results (4491)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multidimensional analysis of B7 homolog 3 RNA expression in small cell lung cancer molecular subtypes
    Journal Article

    Gay, C. M.; Owonikoko, T. K.; Byers, L. A.; Choudhury, N. J.; Ahmed, S.; Cain, Z.; Qian, X.; Brentnall, M.; Heeke, S.; Poi, M.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group
    Review

    Corso, G.; Shen, S.; Criscitiello, C.; Mukhtar, R.; Gamble, L.; Rocco, E. G.; Pesapane, F.; Nicosia, L.; Jhaveri, K.; Salimbeni, B. T.; more...
    Cancer Treatment Reviews (2025)

    Fulltext@MSK | Save
  • Outpatient cytarabine consolidation in acute myeloid leukemia safely reduces hospitalization time and treatment costs
    Journal Article

    Burton, H.; Boussi, L.; Nemirovsky, D.; Derkach, A.; Ciervo, J.; Famulare, C.; Chin, K. K.; Valtis, Y.; Yisraeli Salman, M.; Patel, K.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: A real-world experience
    Journal Article

    Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; more...
    Blood Neoplasia (2025)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma
    Correspondence

    Sebastian, T.; Rajeeve, S.; Farzana, T.; Firestone, R.; Jurgens, E.; Miller, K.; Costa, B.; Lesokhin, A.; Tan, C.; Shah, G.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Phase 2 dose expansion of START-001: A phase 1/2 study of invikafusp alfa (STAR0602), a first-in-class, selective T cell receptor (TCR)-targeting, bifunctional antibody-fusion molecule, as monotherapy in patients with antigen-rich tumors resistant to anti-PD(L)-1
    Meeting Abstract

    Friedman, C. F.; Sullivan, R. J.; Tschernia, N.; Sonpavde, G. P.; Herrera, M.; He, K.; Bilusic, M.; Garralda, E.; Hernando-Calvo, A. H.; Silk, A. W.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • SUPRAME: A phase 3 trial comparing IMA203, an engineered T-cell receptor expressing T cell therapy (TCR-T) vs investigator's choice in patients with previously treated advanced cutaneous melanoma
    Meeting Abstract

    Luke, J. J.; Warner, A. B.; Chmielowski, B.; Diab, A.; Gebhardt, C.; Hernandez-Aya, L. F.; Hu-Lieskovan, S.; Karapetyan, L.; Lawrence, D. P.; McKean, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 1, first-in-human study of CTIM-76, a claudin-6 (CLDN6)-directed bispecific antibody, in patients with recurrent ovarian cancer and other advanced solid tumors
    Meeting Abstract

    O'Cearbhaill, R. E.; Barve, M. A.; Darus, C.; Gabrail, N. Y.; Johannet, P.; Loh, J.; Lerose, M.; Andreas, K.; Ullmann, C. D.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase I study of AFNT-211, autologous CD4(+) and CD8(+) T cells engineered to express a high avidity HLA-A(*)11:01-restricted, KRAS G12V-specific transgenic TCR; CD8α/β coreceptor; and FAS-41BB switch receptor in patients with advanced or metastatic solid tumors
    Meeting Abstract

    Basu, S. K.; Khan, B.; Payumo, F.; Wan, R.; Chiorean, E. G.; Gahvari, Z.; Hecht, J. R.; Hurwitz, M. E.; Leidner, R. S.; Lenz, H. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Body mass index and somatic variants in biliary tract cancers
    Meeting Abstract

    Al Mahmasani, L.; Chou, J. F.; Capanu, M.; Srivastava, A.; Sigel, C. S.; Alsuwailem, R.; Berger, M. F.; Khalil, D. N.; Harding, J. J.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save